Last session

PL

Planet Labs PBC

29

On watch

Planet Labs driven by geopolitical risk

The thesis

Planet Labs provides frequent geospatial data through its satellite constellations. The company is experiencing 42.1% year-over-year revenue growth, despite a negative net margin of -11117.0%. With a conviction score of 42, the company's setup is interesting due to its exposure to rising geopolitical risk. Analysts have a buy consensus rating, but the company's valuation and profitability are concerns.

Why now

Elevated geopolitical risk and recent events, such as China's chip tool push and the US-China squeeze, make this a critical moment for Planet Labs. The company's revenue growth and macro environment make it a compelling watchlist candidate, with 42.1% year-over-year growth amidst rising tensions.

What to watch

Investors should monitor the company's revenue growth and margin expansion over the next few quarters, as well as its ability to navigate rising geopolitical risk. Key indicators to watch include the company's ability to achieve profitability, with a current DCF intrinsic value of -$11, and its progress in executing its satellite constellation deployments.

Key risks

The company's pre-profit status, small revenue base, and sentiment-driven volatility pose significant risks to its valuation and growth prospects. Funding conditions and execution risks also threaten the company's ability to achieve profitability. Additionally, the negative net margin of -11117.0% raises concerns about the company's ability to scale.

Theme exposure

Space

Direct

Planet Labs sits in the satellites layer of the Space story.

Defence & Aerospace

Direct

Planet Labs provides near-daily satellite imaging with growing defence and commercial intelligence customers. Wedbush raised price target in May 2026. Geopolitical tension expands demand for real-time Earth observation.

This brief is generated from our intelligence layers. Treat it as a starting point, not a final word.

Market intelligence only. Not financial advice. Not a recommendation.